Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01714271 · ClinicalTrials.gov registry record · Phase 2
Promotora-based Latino Family CVD Risk Reduction
A Phase 2 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 2
- Development phase
- 204
- Enrollment target
NCT01714271 is a Phase 2 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 204 participants.
The verdict
NCT01714271, a Phase 2 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 204 participants
- Enrollment target
Study Summary
This family environment-focused health behavior change intervention is being carried out by extensively trained community health workers (promotores) familiar with the community in East Los Angeles. The hypothesis being tested is that home environment-focused health behavior change will reduce risk of arterial stiffness, an early-in-life predictor of heart disease. The community health workers will provide most of the health promotion counseling. The promotores will provide up to 16 counseling sessions to a designated adult family member without diabetes. The sessions will focus on improving the home environment in order to reduce television viewing, increase fruit and vegetable intake, decrease intake of refined carbohydrates, prompt more frequent monitoring of body weight and increase daily physical activity. The lifestyle change goals will be tailored to the families' capacity for change and will be consistent with the Dietary Guidelines for Americans, especially the MyPlate.gov messages, the Dietary Approaches to Stop Hypertension (DASH) diet and at least 30 minutes of daily moderate physical activity.
Interventions
- BEHAVIORAL Home environs-based lifestyle counseling
- BEHAVIORAL Cancer early detection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2010-10 |
| Est. Completion | 2014-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01714271
The ClinicalTrials.gov registry entry for NCT01714271 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Home environs-based lifestyle counseling is the first listed.
NCT01714271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01714271 about?
NCT01714271 is a clinical study titled "Promotora-based Latino Family CVD Risk Reduction". This family environment-focused health behavior change intervention is being carried out by extensively trained community health workers (promotores) familiar with the community in East Los Angeles. The hypothesis being tested is that home environment-focused health behavior change will reduce risk ...
What is the current status of trial NCT01714271?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 204 participants. The study started on 2010-10. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01714271?
The interventions under investigation include: Home environs-based lifestyle counseling (BEHAVIORAL), Cancer early detection (BEHAVIORAL).
Who is sponsoring clinical trial NCT01714271?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.